» Articles » PMID: 31132019

Hematopoietic-substrate-1 Associated Protein X-1 (HAX-1) Regulates Liver Cancer Cells Growth, Metastasis, and Angiogenesis Through Akt

Overview
Specialties Oncology
Pharmacology
Date 2019 May 28
PMID 31132019
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the effects and mechanisms of hematopoietic-substrate-1-associated protein X-1 (HAX-1) on liver cancer cells. Information on HAX-1 from liver cancer patients was analyzed by the Cancer Genome Atlas (TCGA) program. Cell migration and invasion abilities were respectively tested by scratch assay and transwell assay. Tube formation assay was applied to detect angiogenesis protein and mRNA was determined using quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. We found that the median month survival of HAX-1 overexpressing liver cancer patients was shorter than that of HAX-1 normal liver cancer patients. HAX-1 was overexpressed in liver cancer tissues and cells, and HAX-1 overexpression promoted the liver cancer cells growth, migration, and invasion, whereas silencing HAX-1 produced the opposite results. Inhibition of Akt by LY294002 reversed the migration and invasion abilities of liver cancer cells, and inhibited the ability of cells growth and angiogenesis. Silencing PIK3CA enhanced the inhibitory effects of HAX-1 silencing on the viability, migration, and invasion of liver cancer cells. HAX-1 affected liver cancer cells metastasis and angiogenesis by affecting Akt phosphorylation and FOXO3A expression.

Citing Articles

Anti-apoptotic HAX-1 suppresses cell apoptosis by promoting c-Abl kinase-involved ROS clearance.

Dong Q, Li D, Zhao H, Zhang X, Liu Y, Hu Y Cell Death Dis. 2022; 13(4):298.

PMID: 35379774 PMC: 8979985. DOI: 10.1038/s41419-022-04748-2.


HAX-1 overexpression in gastric cancer promotes cell proliferation.

Gu S, Zhang S, Huang H, Wang Q, Fan H, Shao Q Transl Cancer Res. 2022; 9(4):2672-2682.

PMID: 35117626 PMC: 8798389. DOI: 10.21037/tcr.2020.02.69.


HAX1 maintains the glioma progression in hypoxia through promoting mitochondrial fission.

Lin J, Wang Y, Lin Z J Cell Mol Med. 2021; 25(24):11170-11184.

PMID: 34755451 PMC: 8650040. DOI: 10.1111/jcmm.17038.


QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis.

Zhao T, Zhou Y, Wang Q, Yi X, Ge S, He H Int J Oncol. 2021; 59(1).

PMID: 34036385 PMC: 8208629. DOI: 10.3892/ijo.2021.5228.


Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Li F, Shang Y, Shi F, Zhang L, Yan J, Sun Q Cancer Manag Res. 2020; 12:9599-9608.

PMID: 33061645 PMC: 7537805. DOI: 10.2147/CMAR.S274892.


References
1.
Yuan J, Govindarajan S, Arakawa K, Yu M . Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer. 2004; 101(5):1009-17. DOI: 10.1002/cncr.20427. View

2.
Chen J, Wang Q, Fu X, Huang X, Chen X, Cao L . Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res. 2009; 39(2):177-86. DOI: 10.1111/j.1872-034X.2008.00449.x. View

3.
Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y . TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010; 463(7281):676-80. DOI: 10.1038/nature08734. View

4.
Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

5.
Kashiwagi A, Fein M, Shimada M . Calpain modulates cyclin-dependent kinase inhibitor 1B (p27(Kip1)) in cells of the osteoblast lineage. Calcif Tissue Int. 2011; 89(1):36-42. PMC: 3111891. DOI: 10.1007/s00223-011-9491-3. View